NCT00781911 2019-09-20A Study of Cixutumumab (IMC-A12) in Islet Cell CancerEli Lilly and CompanyPhase 2 Completed43 enrolled 12 charts
NCT01263782 2019-05-15BATTLE-FL: Front-Line Biomarker-Integrated Treatment Study in Non Small Cell Lung CancerM.D. Anderson Cancer CenterPhase 2 Completed64 enrolled 12 charts